These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 1376317)

  • 1. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
    Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
    J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
    Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
    J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin cleavage of vitronectin. Identification of the site and consequent attenuation in binding plasminogen activator inhibitor-1.
    Chain D; Kreizman T; Shapira H; Shaltiel S
    FEBS Lett; 1991 Jul; 285(2):251-6. PubMed ID: 1713175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.
    Owensby DA; Morton PA; Wun TC; Schwartz AL
    J Biol Chem; 1991 Mar; 266(7):4334-40. PubMed ID: 1705551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin.
    Seiffert D; Loskutoff DJ
    J Biol Chem; 1991 Feb; 266(5):2824-30. PubMed ID: 1704366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator.
    Preissner KT
    Biochem Biophys Res Commun; 1990 May; 168(3):966-71. PubMed ID: 1693270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.
    Seiffert D; Ciambrone G; Wagner NV; Binder BR; Loskutoff DJ
    J Biol Chem; 1994 Jan; 269(4):2659-66. PubMed ID: 7507927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function.
    Chavakis T; Pixley RA; Isordia-Salas I; Colman RW; Preissner KT
    J Biol Chem; 2002 Sep; 277(36):32677-82. PubMed ID: 12082110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.
    Keijer J; Linders M; Wegman JJ; Ehrlich HJ; Mertens K; Pannekoek H
    Blood; 1991 Sep; 78(5):1254-61. PubMed ID: 1715220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.
    Kost C; Benner K; Stockmann A; Linder D; Preissner KT
    Eur J Biochem; 1996 Mar; 236(2):682-8. PubMed ID: 8612645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the plasminogen activator inhibitor-1 binding heptapeptide in vitronectin.
    Mimuro J; Muramatsu S; Kurano Y; Uchida Y; Ikadai H; Watanabe S; Sakata Y
    Biochemistry; 1993 Mar; 32(9):2314-20. PubMed ID: 7680229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin.
    Ehrlich HJ; Keijer J; Preissner KT; Gebbink RK; Pannekoek H
    Biochemistry; 1991 Jan; 30(4):1021-8. PubMed ID: 1703436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited proteolysis of vitronectin by plasmin destroys heparin binding activity.
    Sane DC; Moser TL; Greenberg CS
    Thromb Haemost; 1991 Sep; 66(3):310-4. PubMed ID: 1720904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
    Mimuro J; Loskutoff DJ
    J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
    Ehrlich HJ; Gebbink RK; Keijer J; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1990 Aug; 265(22):13029-35. PubMed ID: 1695900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
    Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.
    Seiffert D; Wagner NN; Loskutoff DJ
    J Cell Biol; 1990 Sep; 111(3):1283-91. PubMed ID: 1697297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin.
    de Boer HC; Preissner KT; Bouma BN; de Groot PG
    J Biol Chem; 1992 Feb; 267(4):2264-8. PubMed ID: 1370815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
    Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
    J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product.
    Mulligan-Kehoe MJ; Wagner R; Wieland C; Powell R
    J Biol Chem; 2001 Mar; 276(11):8588-96. PubMed ID: 11113116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.